In malaria-endemic geographies such as Brazil, G6PD deficiency has important clinical implications for the radical cure of P. vivax malaria with 8-aminoquinoline drugs, which can lead to adverse health outcomes among patients with low G6PD activity [9]. The gene discussed is G6PD; the disease is G6PD deficiency.